Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
PubMed , Fenton, Anna
Adverse events were reported infrequently and were minor
Very convincing data that combined therapy with SGLT-2i and GLP-1 RA is much more efficacious in decreasing CV, renal and HF outcomes than monotherapies This is somehing that all of us expects but we have no strong prospective randomized data Also, the safety of combination appears to be fine Nice paper on a very important topic
Bagur MJ, Murcia MA, Jimnez-Monreal AM, et al
US$ 20.23
US$ 22.23
US$ 27.72
